NESTABS description, usages, side effects, indications, overdosage, supplying and lots more!

NESTABS

WOMENS CHOICE PHARMACEUTICALS LLC
WOMENS CHOICE PHARMACEUTICALS LLC

  • Description
  • Clinical Pharmacology
  • Indications & Usage
  • Contraindications
  • Warnings
  • Precautions
  • Side Effects
  • Overdosage
  • Dosage & Administration
  • How Supplied
  • Patient Counseling Information
  • Supplemental Patient Material
  • Boxed Warning
  • Patient Package Insert
Nestabs



FULL PRESCRIBING INFORMATION


WARNING:  Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.  Keep this product out of the reach of children.  In case of accidental overdose, call a doctor or poison control center immediately.

Description: Nestabs tablets for oral administration is a light pink capsule shaped film coated tablet with a pleasant sweet flavor with WC001 imprinted on one side of the tablet.

Uses

Indications and Usage:  Nestabs is indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers.  Nestabs is also beneficial in improving the nutritional status of women prior to conception.

Contraindications:  This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Warnings:  Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

  Precautions:  Folic acid in doses above 0.1mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive.  This product contains formate, which if consumed above the recommended level, could cause visual impairment and other health effects.  Do not take more than the recommended amount.  If you are pregnant, nursing, or taking any medications consult your doctor before use.  Discontinue use and consult your doctor if any adverse reactions occur.  Not intended for use by persons under the age of 18.

Dosage and Administration:  One tablet daily or as directed by a physician.

NESTABS

Multi-vitamin/Mineral Supplement with Sodium Ascorbate, Cholecalciferol, di-alpha-Tocopheryl Acetate, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine HCL, Folic Acid, Cyanocobalamin, Calcium Formate, Calcium Carbonate, Ferrous (II) bis-Glycinate Chelate, Potassium Iodide, Zinc Oxide, and Choline Bitartrate TABLET, FILM COATED

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:50967-219
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
sodium ascorbate ASCORBIC ACID 120 mg
CHOLECALCIFEROL CHOLECALCIFEROL 450 [iU]
.ALPHA.-TOCOPHEROL ACETATE, D- 30 [iU]
THIAMINE MONONITRATE THIAMINE ION 3 mg
RIBOFLAVIN RIBOFLAVIN 3 mg
NIACINAMIDE 20 mg
PYRIDOXINE HYDROCHLORIDE PYRIDOXINE 50 mg
FOLIC ACID FOLIC ACID 1 mg
Cyanocobalamin CYANOCOBALAMIN 10 ug
Calcium formate CALCIUM CATION 155 mg
CALCIUM CARBONATE 45 mg
ferrous bisglycinate FERROUS CATION 32 mg
Potassium Iodide IODIDE ION 100 ug
Zinc Oxide Zinc oxide 10 mg
choline bitartrate 55 mg

Inactive Ingredients

Ingredient Name Strength
cellulose, microcrystalline
MAGNESIUM STEARATE
povidone
POLYVINYL ALCOHOL
titanium dioxide
talc
FD&C RED NO. 40
ALUMINUM OXIDE
SACCHARIN
carnauba wax

Product Characteristics

Color Size Imprint Code Shape
pink (WC;001) 18 mm WC;001 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:50967-219-90 1 in 1 BOTTLE, PLASTIC

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
2011-02-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.